trastuzumab
Published:
A monoclonal antibody that binds to HER2 (human epidermal growth factor receptor), and can kill HER2-positive cancer cells. Monoclonal antibodies are made in the laboratory and can locate and bind to cancer cells. Trastuzumab is used to treat breast cancer that is HER2-positive and has spread after treatment with other drugs. It is also used with other anticancer drugs to treat HER2-positive breast cancer after surgery. Trastuzumab is also being studied in the treatment of other types of cancer. Also called Herceptin.